Chongqing Hifuture Information Technology Co., Ltd. (SHE:002168)
China · Delayed Price · Currency is CNY 3.560
-0.010 (-0.28%)
Sep 30, 2026, 3:04 PM CST
SHE:002168 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 359.89 | 369.14 | 197.24 | 254.16 | 244.41 | 329.91 |
Revenue Growth | 35.43% | 87.16% | -22.40% | 3.99% | -25.92% | -57.97% |
Gross Profit Gross Profit Growth | 184.51 | 178.2 | 18.71 | 73.17 | 70.68 | 113.57 |
Operating Income Operating Income Growth | -5.18 | -5.15 | -103.13 | -106.68 | -93.15 | -184.31 |
Net Income Net Income Growth | -69.72 | -79.02 | -149.52 | 1.9 | -115.53 | -222.85 |
Earnings Per Share EPS Growth | -0.09 | -0.10 | -0.19 | 0.00 | -0.15 | -0.28 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Pharmaceutical Business Segment Pharmaceutical Business Segment Growth | 259.51 | 217.86 | - |
Electric Business Segment Electric Business Segment Growth | 49.99 | 65.38 | 130.38 |
New Energy Business Segment New Energy Business Segment Growth | 65.51 | 92.18 | 63.88 |
Unallocated Other Unallocated Other Growth | - | - | 2.98 |
Offset of Business Segment Offset of Business Segment Growth | - | -6.29 | - |
Total Total Growth | 359.89 | 369.14 | 197.24 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 51.35 | 67.9 | 38.73 | 71.51 | 94.16 | 80.78 |
Total Debt Total Debt Growth | 336.1 | 366.58 | 514.49 | 569.75 | 501.93 | 496.16 |
Net Cash (Debt) Net Cash Growth | -284.75 | -298.68 | -475.76 | -498.24 | -407.77 | -415.38 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.36 | -0.38 | -0.61 | -0.63 | -0.53 | -0.52 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 46.39 | 92.78 | -118.75 | 28.55 | 19.02 | 207.76 |
Capital Expenditures CapEx Growth | -0.73 | -1.5 | -9.55 | -60.14 | -5.92 | -9.08 |
Free Cash Flow Free Cash Flow Growth | 45.66 | 91.28 | -128.3 | -31.59 | 13.09 | 198.69 |
Free Cash Flow Growth | - | - | - | - | -93.41% | 57.53% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 51.27% | 48.28% | 9.48% | 28.79% | 28.92% | 34.42% |
Operating Margin | -1.44% | -1.40% | -52.29% | -41.98% | -38.11% | -55.87% |
Pretax Margin | -8.81% | -12.73% | -62.83% | 2.80% | -45.80% | -78.51% |
Profit Margin | -19.37% | -21.41% | -75.81% | 0.75% | -47.27% | -67.55% |
FCF Margin | 12.69% | 24.73% | -65.05% | -12.43% | 5.36% | 60.22% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 1892.90 | - | - |
Forward PE | - | 60.62 | 60.62 | 60.62 | 60.62 | 60.62 |
P/FCF Ratio | 61.14 | 36.08 | - | - | 240.46 | 16.93 |
PS Ratio | 7.76 | 8.92 | 11.01 | 14.13 | 12.88 | 10.20 |